Coya Therapeutics publishes preclinical study on COYA 303 combination effects
Coya Therapeutics said it has published preclinical results for COYA 303 in the International Journal of Molecular Sciences, describing combination immunomodulatory effects in a model of peripheral and CNS inflammation.
Story updates
12:05:15 PM UTC
SquawkNews
COYA - Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.